在内分泌高血压中cAMP/PKA信号:遗传机制和病理生理学的见解
Jose Antonio B Lima Sobrinho1, Madson Q Almeida1,2
1Unidade de Adrenal, Laboratório de Endocrinologia Molecular e Celular Laboratório de Investigação Médica 25' (LIM25), Divisão de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Frontiers in endocrinology
|March 12, 2026
概括
循环腺单酸盐 (cAMP) -蛋白激酶A (PKA) 途径的失调会通过GNAS和PRKAR1A等关键基因的遗传变化驱动高血压,影响上腺功能和血压.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环腺单酸 (cAMP) - 蛋白激酶A (PKA) 信号通路对于上腺功能,类固醇生成和血压调节至关重要.
- 对cAMP/PKA通路的失调越来越多地与各种形式的高血压有关,包括内分泌和非内分泌类型.
研究的目的:
- 审查cAMP/PKA通路组件中生殖线和体质变化的作用,作为高血压疾病的驱动因素.
- 突出特定的遗传变异及其与不同高血压表型和上腺疾病的关联.
主要方法:
- 对调查cAMP/PKA通路基因遗传变化的研究的文献综述.
- 分析了GNAS,PRKAR1A,PDE11A,PDE8B,PRKACA,PDE2A,PDE3B和PDE3A等基因中的致病变体与高血压疾病和上腺病理之间的关联.
主要成果:
- 激活GNAS变体与皮质醇过量,麦库恩-阿尔布赖特综合征和库辛综合征有关.
- 失活PRKAR1A变体与卡尼复杂和原发性色素结节性上腺皮质疾病 (PPNAD) 有关.
- 像PDE11A,PDE8B,PDE2A,PDE3B和PDE3A这样的基化酶 (PDEs) 的变化与库辛综合征,上腺增生和家族性高血压有关.
结论:
- 这种cAMP/PKA通路在各种高血压表型的病理生理学中发挥着关键作用.
- 在cAMP/PKA通路组件中的遗传变化代表了高血压背后的新型分子机制.
- 这些发现表明,与cAMP/PKA信号传递相关的高血压疾病的潜在新治疗点.
相关概念视频
01:45Endocrine Signaling
69.0K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
69.0K
01:45Endocrine Signaling
7.1K
7.1K
01:29Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
01:25cAMP-dependent Protein Kinase Pathways
8.9K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.9K
01:17Hormonal Regulation of Blood Pressure
7.0K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.0K
01:18Hypertension and Regulation of Blood Pressure
4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K